Found: 21
Select item for more details and to access through your institution.
Types of Liquid Biopsies: Understanding the Different Lenses Through Which They Can Detect Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 281, doi. 10.1093/oncolo/oyad006
- By:
- Publication type:
- Article
KRAS: Druggable at Last.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 283, doi. 10.1093/oncolo/oyad014
- By:
- Publication type:
- Article
Practical Guidance for the Management of Adverse Events in Patients with KRASG12C-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 287, doi. 10.1093/oncolo/oyad051
- By:
- Publication type:
- Article
Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 297, doi. 10.1093/oncolo/oyac263
- By:
- Publication type:
- Article
Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 309, doi. 10.1093/oncolo/oyac260
- By:
- Publication type:
- Article
Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 319, doi. 10.1093/oncolo/oyad025
- By:
- Publication type:
- Article
Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 327, doi. 10.1093/oncolo/oyac273
- By:
- Publication type:
- Article
Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 333, doi. 10.1093/oncolo/oyac243
- By:
- Publication type:
- Article
Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 341, doi. 10.1093/oncolo/oyac251
- By:
- Publication type:
- Article
Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 351, doi. 10.1093/oncolo/oyac266
- By:
- Publication type:
- Article
Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 358, doi. 10.1093/oncolo/oyac281
- By:
- Publication type:
- Article
Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 364, doi. 10.1093/oncolo/oyac244
- By:
- Publication type:
- Article
Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 366, doi. 10.1093/oncolo/oyac224
- By:
- Publication type:
- Article
Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 368, doi. 10.1093/oncolo/oyac204
- By:
- Publication type:
- Article
Mobile Health Application-Based Interventions to Improve Self-management of Chemotherapy-Related Symptoms Among People with Breast Cancer Who Are Undergoing Chemotherapy: A Systematic Review.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. e175, doi. 10.1093/oncolo/oyac267
- By:
- Publication type:
- Article
CT Radiomics for Predicting Pathological Complete Response of Axillary Lymph Nodes in Breast Cancer After Neoadjuvant Chemotherapy: A Prospective Study.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. e183, doi. 10.1093/oncolo/oyad010
- By:
- Publication type:
- Article
Activity of Anlotinib in the Second-Line Therapy of Metastatic Gastrointestinal Stromal Tumors: A Prospective, Multicenter, In Vitro Study.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. e191, doi. 10.1093/oncolo/oyac271
- By:
- Publication type:
- Article
Feasibility of a Geriatric Oncology Longitudinal End to End (GOLDEN) Program in a Tertiary Cancer Center in Singapore.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. e198, doi. 10.1093/oncolo/oyac276
- By:
- Publication type:
- Article
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. e205, doi. 10.1093/oncolo/oyad043
- By:
- Publication type:
- Article
Humoral Response of Patients With Cancer to Breakthrough COVID-19 Infection or the Fourth BNT162b2 Vaccine Dose.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. e225, doi. 10.1093/oncolo/oyad003
- By:
- Publication type:
- Article
Oncologist Participation and Performance in the Merit-Based Incentive Payment System.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. e228, doi. 10.1093/oncolo/oyad033
- By:
- Publication type:
- Article